DIA Europe 2019 has ended
Back To Schedule
Wednesday, February 6 • 09:15 - 10:15
#DMD7: Digital Trials, Sensors, Bots, AI/Machine Learning, RWD– Will Product Approvals Be Accelerated By These New Technologies?

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session

Digital trials or “smart” trials, AI, Bots are the new buzzwords in our industry. But what do we mean by digital trials and how will these new technologies accelerate product approvals? Drug development timelines and cost keep increasing while reimbursement is diminishing; a paradigm shift is needed in the way we develop drugs. Will this come from new technologies and digitisation? And how will these technologies impact drug development process? What are the implications for regulators and how will they approve usage of sensors, bots and ML algorithm. Do pharma and regulators need to adapt their process and organisations (e.g., introduce a Chief Digital Officer role). And finally, will the patients accept these new technologies with increasing patient adherence and preparing a natural continuum with mHealth?


Isabelle M de Zegher, DrMed, MD, MS, MSc


Panel Discussion
Ulo Palm, MD, PhD, MBA

Panel Discussion
Thomas Senderovitz, DrMed, MD

Panel Discussion
Peter Shone

Panel Discussion
Meni Styliadou


Ulo Palm

Senior Vice President, Head Global Drug Development Operations, Allergan
avatar for Thomas Senderovitz

Thomas Senderovitz

Chair of HMA Management Group; Director General, Danish Medicines Agency
Thomas Senderovitz took over as Director General of the Danish Medicines Agency on 1 April 2016. His career includes more than 20 years working with medicinal products and he has held several senior positions in international biopharmaceutical Companies. He previously worked at the... Read More →

Peter Shone

Corporate Vice President, R&D Engineering, PAREXEL Informatics

Meni Styliadou

VP Government Affairs & Public Policy, Europe & Canada, Takeda
avatar for Isabelle de Zegher

Isabelle de Zegher

Vice President, PAREXEL Informatics
Isabelle de Zegher is Vice President, Integrated Solutions at PAREXEL Informatics where she is responsible for engineering strategy around Big Data, BI and Advanced Analytics. She has 25 years’ experience in Life Sciences, including extensive work on cross-industry forum on integration... Read More →

Wednesday February 6, 2019 09:15 - 10:15 CET
E1 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  DIAmond Sessions, Session
  • Featured Topics Data and Data Standards
  • Tags Session